First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
24 hedge funds and large institutions have $8.12M invested in First Trust Nasdaq Pharmaceuticals ETF in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$598K | |
| 2 | +$570K | |
| 3 | +$530K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$346K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$168K |
Top Sellers
| 1 | -$1.26M | |
| 2 | -$517K | |
| 3 | -$232K | |
| 4 |
WFA
WMG Financial Advisors
Knoxville,
Tennessee
|
-$58.7K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$30.1K |